Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.78 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL28737611 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL6018199 | 0.94 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL9879794 | 0.94 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL50017 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL25179700 | 0.88 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL485780 | 0.88 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL193975 | 0.88 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL20658052 | 0.88 | — | — | |
| Oxalic Acid SCHEMBL21951275 | 0.88 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL20543321 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118616078-A | Preparation method and application of nitrogen-doped carbon nanotube-encapsulated low-loading rare earth/nickel catalyst | 攀枝花学院 | 2024-09-10 | — | — | CN | claimed |
| CN-118479524-A | Preparation method of ytterbium oxide for target material | 江西明达功能材料有限责任公司 | 2024-08-13 | — | — | CN | claimed |
| CN-114935265-A | Flash calcining method and flash calcining equipment | 江西闪凝科技有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-112774676-B | Rare earth oxide supported ruthenium catalyst and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2021-12-14 | — | — | CN | claimed |
| CN-112774676-A | Rare earth oxide supported ruthenium catalyst and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2021-05-11 | — | — | CN | claimed |
| CN-106861601-B | A kind of CO of ytterbium doping2Adsorbent and preparation method thereof | 华中科技大学 | 2019-08-13 | — | — | CN | claimed |
| CN-106861601-A | A kind of CO of ytterbium doping2Adsorbent and preparation method thereof | 华中科技大学 | 2017-06-20 | — | — | CN | claimed |
| CN-104987049-A | Preparation method of acid-resisting alumina based ceramsite fracturing propping agent | UNIV GUILIN TECH GUT | 2015-10-21 | — | — | CN | claimed |
| CN-103066292-A | Grapheme/rare earth oxide nanometer composite material and preparation method and application thereof | UNIV TONGJI | 2013-04-24 | — | — | CN | claimed |
| CN-101823689-B | Method for preparing porous metal oxide-coated carbon nanotube composite material | HARBIN INST OF TECHNOLOGY | 2012-12-26 | — | — | CN | claimed |
| CN-101823689-A | Method for preparing porous metal oxide-coated carbon nanotube composite material | HARBIN INST OF TECHNOLOGY | 2010-09-08 | — | — | CN | claimed |
| CN-100500683-C | Method for distilling tannin from plant | UNIV XIAMEN (CN) | 2009-06-17 | — | — | CN | claimed |
| CN-1872863-A | Method for distilling tannin from plant | UNIV XIAMEN (CN) | 2006-12-06 | — | — | CN | claimed |
| WO-2005054132-A1 | TAGGED POLYMERIC MATERIALS AND METHODS FOR THEIR PREPARATION | ORICA AUSTRALIA PTY LTD (AU) | 2005-06-16 | — | — | WO | claimed |
| CN-122070995-A | Methyl mercaptan oxidation catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260018314-A1 | PRODUCTION OF LU-177 AND OTHER RADIONUCLIDES VIA HOT ATOM CAPTURE ON NANOSTRUCTURED CARBON BY DRYING A SOLUTION PRIOR TO IRRADIATION | UNIV TEXAS (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250269327-A1 | ELECTRO-AMALGAMATION APPARATUS AND METHOD FOR SEPARATING PRODUCT AND NON-PRODUCT LANTHANIDES | MCMASTER UNIVERSITY (CA) | 2025-08-28 | — | — | US | disclosed |
| EP-1016547-A1 | Method and material for erasable recording by heat | Ricoh Company, Ltd. (JP) | 2000-07-05 | — | — | EP | disclosed |
| CN-1089751-A | Make the method for superconductor and the product for preparing with superconductor | UNIV QUEENSLAND (AU) | 1994-07-20 | — | — | CN | disclosed |
| US-4803291-A | FROM OXALIC ACID AND METAL SALT, MAGNETIC RECORDING MEDIA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1989-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260018314-A1 | PRODUCTION OF LU-177 AND OTHER RADIONUCLIDES VIA HOT ATOM CAPTURE ON NANOSTRUCTURED CARBON BY DRYING A SOLUTION PRIOR TO IRRADIATION | NPM1, SSTR2, SSTR3 | CA4 621/4885FAHD1 3787/4885MEN1 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.